Testing effectiveness (Phase 2)WithdrawnNCT02674269
What this trial is testing
Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")
Who this might be right for
Overactive Bladder
UroGen Pharma Ltd.